Scenarios that move OGN

Organon & Co. Common Stock

Scenarios that move OGN: 4 analyses, 2 positive, 2 negative.

  1. · HALO wins court order blocking Merck's European Keytruda SC — ▲ · impact +20 · confidence low · horizon quarters
  2. · Oruka Therapeutics reports positive week 28 ORKA-001 trial data — ▼ · impact -8 · confidence low · horizon quarters
  3. · ◇ What if… Samuel Alito announces retirement by December 31, 2026 — ▼ · impact -30 · confidence low · horizon quarters
  4. · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▲ · impact +15 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing